It is the responsibility of the LAHBPA to help grow our industry and provide our horsemen the best opportunity to succeed financially and to compete with other racing jurisdictions. During the past several years it has become evident that our thoroughbred horsemen have only had the opportunity to compete for adequate purse money six months out the year (October through March). The other six months of the year, our horsemen participate, at lower purses, which prompt some to leave the state and race in other racing jurisdictions. Recognizing this dilemma and to prevent it from adversely affecting the industry, the LAHBPA worked directly with Senator LaFleur in proposing legislation that would provide a mechanism to transfer a portion of purse money from one Licensed Eligible Facility (Race Track) to another Licensed Eligible Facility (Race Track). This legislation, SB 525 was filed and ultimately passed by both houses and signed into law on May 30, 2018. The LAHBPA met directly with
NOTICE RACING COMMISSION BANS USE OF CLENBUTEROL IN QUARTER HORSES
At the July 16th meeting, the Racing Commission voted to ban the use of Clenbuterol in Quarter Horses effective the first day of the Evangeline Downs meet, or October 3, 2018.
The detection of Clenbuterol AT ANY LEVEL will constitute a violation of a Class 3 drug, thereby necessitating a penalty of:
1) The suspension of license for a period of not less than 60 days and not more than six months and/or a fine of not more than $1,500.
2) The purse shall be redistributed.
The HBPA is requested to notify its Quarter Horse members of the ban on Clenbuterol and Racing Associations are requested to post this notice in all conspicuous places, including but not limited, to Racing Offices, Backstretch Stable Gates, Track Kitchens, Condition Books, Overnight Sheets, etc.
Further possible sanctions, including placing the positive horse on the Vets or Stewards Lists for a certain period of time or until the positive horse tests negative for Clenbuterol will be discussed at the Racing Commission on August 27th at the Hotel Monteleone in New Orleans.